Karolinska Development
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
- Sector:
- Financial and insurance activities
- Industry:
- Other financial service activities, except insurance and pension funding activities
Description
Karolinska Development is a Nordic life sciences investment company that focuses on identifying, financing, and developing companies with breakthrough medical innovations. Founded in 2003 to commercialize promising academic research, the firm manages a diversified portfolio of early-stage and growth-stage pharmaceutical, biotechnology, and medtech companies. Karolinska Development leverages its team's expertise in research, finance, and commercialization to advance portfolio companies' projects into ground-breaking treatments for serious diseases. The company's primary objective is to create value and generate high returns for its shareholders through strategic exits, including public listings and trade sales.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Karolinska Development.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-29 08:00 |
Interim Report
|
Swedish | 1.9 MB | |
| 2025-08-29 08:00 |
Interim Report
|
English | 1.8 MB | |
| 2025-05-15 16:45 |
Post-Annual General Meeting Information
Karolinska Developments årsstämma 2025
|
Swedish | 62.6 KB | |
| 2025-05-15 16:45 |
Post-Annual General Meeting Information
Karolinska Development’s Annual General Meeting 2025
|
English | 74.3 KB | |
| 2025-04-30 08:00 |
Quarterly Report
|
Swedish | 1.7 MB | |
| 2025-04-30 08:00 |
Quarterly Report
|
English | 1.8 MB | |
| 2025-03-21 08:00 |
Annual Report (ESEF)
|
Swedish | 1.9 MB | |
| 2025-03-21 08:00 |
Annual Report (ESEF)
|
Swedish | 1.9 MB | |
| 2025-02-14 08:00 |
Earnings Release
|
Swedish | 1.8 MB | |
| 2025-02-14 08:00 |
Annual Report
|
English | 1.7 MB | |
| 2024-12-18 16:30 |
Board/Management Information
Karolinska Developments styrelse utser Ben Toogood till ny ordförande
|
Swedish | 49.1 KB | |
| 2024-12-18 16:30 |
Board/Management Information
Karolinska Development’s Board of Directors appoints Ben Toogood as new Chairman
|
English | 62.9 KB | |
| 2024-12-11 11:45 |
Board/Management Information
Karolinska Development’s Chairman of the Board resigns at his own request
|
English | 73.4 KB | |
| 2024-12-11 11:45 |
Board/Management Information
Karolinska Developments styrelseordförande avgår på egen begäran
|
Swedish | 53.0 KB | |
| 2024-12-02 16:42 |
Board/Management Information
Karolinska Development implements organizational changes for more efficient por…
|
English | 79.8 KB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
/other/I_Love_Lund_AB_publ-logo.png){kind=logo}
